F. Hadziselimovic et al., THE INCIDENCE OF SEMINOMA AND EXPRESSION OF CELL-ADHESION MOLECULE CD44 IN CRYPTORCHID BOYS AND INFERTILE MEN, The Journal of urology, 157(5), 1997, pp. 1895-1897
Purpose: The incidence of seminoma in men with cryptorchid testes is a
contentious issue among physicians. Nevertheless, a positive correlat
ion has been shown between the susceptibility for seminoma in patients
with the oligo-asthenoteratospermia syndrome and in those with crypto
rchid testes. Materials and Methods: We histologically examined 5,231
biopsies from 3,867 patients, including 1,121 men with the oligo-asthe
noteratospermia syndrome, 218 men with azoospermia and 2,528 boys with
cryptorchidism. Testicular tissue embedded in Epon was analyzed by li
ght microscopy, fluorometry, electron microscopy and immunohistochemis
try. Cell adhesion molecule CD44 was detected using a monoclonal antib
ody in all biopsies of patients suspected of having carcinoma in situ.
Results: The incidence of seminoma was identical in boys with cryptor
chidism and infertile men with the oligo-asthenoteratospermia syndrome
but it was significantly higher than in the normal population. All bi
opsies were analyzed by a single investigator, including 2,528 from 2,
403 cryptorchid boys and 2,322 from 1,339 infertile men. Seminoma was
found in 4 cryptorchid boys of whom 3 had intra-abdominal testes. The
incidence of seminoma in infertile men with the oligo-asthenoteratospe
rmia syndrome was 6/1,121 (4 stage I and 2 stage II). Overall 10 semin
omas were noted in 3,867 patients, including 1 in whom seminomas subse
quently developed in both testes. Before the onset of puberty primordi
al germ cells persisted in 7 of the 2,528 cryptorchid patients, althou
gh no invasive seminomas were detected. An anti-CD44 monoclonal antibo
dy was found to bind selectively to seminoma cells in the earliest sta
ges of malignant transformation and metastasis, which to our knowledge
represents the first reported incidence of CD44 expression associated
with seminoma cells. Conclusions: The incidence of carcinoma in situ
in patients with the oligo-asthenoteratospermia syndrome or cryptorchi
dism was 0.27%. If the occurrence of primordial germ cells is consider
ed, the overall incidence was 0.46% (17 of 3,659 cases). CD44 was expr
essed in all seminoma cells as well as in all primordial germ cells. B
ecause CD44 adhesion molecules are expressed in the earliest stages of
seminoma development, anti-CD44 monoclonal antibody is an important n
ew tool for positively identifying this type of neoplasm in all cases.